Immunogenic Consideration of a Designed Polypeptide Against Brucellosis Compared to RB51: An In Vivo Study
Designed recombinant polypeptide combined with chitin showed ability for induction of cellular and humoral immunity an guinea pigs compared to RB51 vaccine.
Authors
- Mina Saadat
- Nariman Mosaffa (ORCID: https://orcid.org/0000-0003-1695-782X)
- Bahram Kazemi (ORCID: https://orcid.org/0000-0001-8448-3406)
- Mojgan Bandehpour (ORCID: https://orcid.org/0000-0002-5309-9476)
Institutions
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- Avicenna Journal of Medical Biotechnology
- Published
- 2024-10-19
- DOI
- https://doi.org/10.18502/ajmb.v16i4.16741
- Primary Topic
- Brucella: diagnosis, epidemiology, treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shahid Beheshti University of Medical Sciences